MAPT and Alzheimer disease: These outcomes implied that HA@Rhy@Hf-MOF exhibits effectiveness in treating AD by targeting the deposition of Aβ plaques and inhibiting site-specific phosphorylation of Tau, thereby exerting protective effects on neurons.